Aetna Back Pain Invasive Procedures Policy Update (CPB 0016) — What Billing Teams Need to Know

Aetna's Clinical Policy Bulletin 0016, covering invasive procedures for back pain, has been modified with an effective date of February 12, 2026. For pain management practices, spine surgery centers, orthopedic groups, and neurosurgery practices, CPB 0016 is one of the most consequential coverage policies in the Aetna book — it governs whether procedures ranging from spinal cord stimulation to facet joint injections meet medical necessity criteria. Any modification to this policy can directly affect authorization approvals, claim denials, and revenue recovery timelines.

What Is Aetna CPB 0016 and Why It Matters for Back Pain Billing

Clinical Policy Bulletin 0016 is Aetna's foundational coverage policy for invasive interventions targeting back pain — one of the highest-volume diagnoses in the U.S. healthcare system. The policy governs a broad range of procedures, including epidural steroid injections, facet joint injections, medial branch blocks, radiofrequency ablation (neurotomy), spinal cord stimulation, intradiscal procedures, and surgical interventions for degenerative spinal conditions.

Aetna, a CVS Health company, uses CPB 0016 to define which of these procedures are considered medically necessary, which are covered only under specific clinical criteria, and which remain classified as experimental or investigational. Because back pain procedures are both high-utilization and high-cost, payers scrutinize these claims closely — meaning even small policy revisions can trigger significant upstream effects on authorization workflows and downstream effects on reimbursement.

This February 2026 modification represents a formal update to the policy's criteria, coverage designations, or experimental/investigational classifications. Billing teams and RCM directors should treat any modification to CPB 0016 as a high-priority compliance event.

What Typically Changes in an Aetna Back Pain Invasive Procedure Policy Update

Because the specific line-level changes from this modification have not been published in a publicly accessible summary at the time of writing, the following section draws on the documented structure of CPB 0016 and the types of changes Aetna has historically made to this policy. For a line-by-line version diff showing exactly what changed in this February 2026 update, see PayerPolicy's full policy comparison tool.

CPB 0016 has historically addressed the following categories of coverage:

Procedures likely addressed as covered with criteria met:

• Epidural corticosteroid injections for radiculopathy
• Facet joint injections and medial branch blocks (with diagnostic criteria and frequency limits)
• Radiofrequency ablation following confirmed diagnostic block response
• Spinal cord stimulation for failed back surgery syndrome or complex regional pain syndrome
• Lumbar discectomy and spinal fusion under defined surgical necessity criteria

Procedures historically designated experimental or investigational under CPB 0016:

• Intradiscal electrothermal therapy (IDET)
• Percutaneous intradiscal radiofrequency thermocoagulation
• Annuloplasty procedures
• Certain biologics or cell-based injections into the disc or facet joints

Policy modifications in this category typically involve one or more of the following changes: updating the number of allowed injections per region per year, tightening or loosening conservative care prerequisites (e.g., weeks of physical therapy required before authorization), reclassifying a procedure from experimental to covered or vice versa, or revising the imaging or diagnostic documentation required to support medical necessity.

Prior Authorization Requirements for Aetna Back Pain Procedures

Prior authorization is a standard requirement for the vast majority of invasive back pain procedures under Aetna's policies. CPB 0016 works in concert with Aetna's prior authorization lists to determine which procedures require advance approval before services are rendered.

For procedures that fall under CPB 0016 coverage criteria, authorization requests typically require:

• Documentation of the specific diagnosis with supporting imaging (MRI, CT, or X-ray as appropriate)
• Evidence of conservative treatment failure, including the type, duration, and outcome of physical therapy or other non-invasive care
• Physician documentation of the clinical rationale for the specific procedure requested
• Procedure-specific criteria — for example, a successful diagnostic block before requesting radiofrequency ablation authorization

Any modification to CPB 0016 may alter these prerequisite requirements. Your team should pull the updated policy in full and cross-reference it against your current authorization templates before submitting any requests dated on or after February 12, 2026.

Affected Codes

The February 2026 update to CPB 0016 does not include a publicly available code list in the data provided to PayerPolicy at this time. The policy does not list specific codes in the summary data available for this post.

For complete CPT, HCPCS, and ICD-10-CM code tables associated with CPB 0016 — including covered codes, non-covered codes, and experimental/investigational designations — access the full policy via the PayerPolicy source link or your Aetna provider portal.

Historically, CPB 0016 has included CPT codes across the following procedure families: epidural injections (62320–62327), facet joint injections (64490–64495), medial branch blocks (64490–64495), radiofrequency ablation (64633–64636), spinal cord stimulation (63650–63688), and surgical decompression/fusion codes in the 22xxx range. Do not bill against this list without confirming the current policy version applies these codes — the February 2026 modification may have changed coverage designations for specific codes.

What Your Billing Team Should Do